The construction of the high liter and highly expressed safety retroviral vector carrying human clotting factor IX cDNA is reported. Retroviral vectors LNCTX, LIXSN and LCTXSN, driven by hCMV, LTR and hCMV combined wi...The construction of the high liter and highly expressed safety retroviral vector carrying human clotting factor IX cDNA is reported. Retroviral vectors LNCTX, LIXSN and LCTXSN, driven by hCMV, LTR and hCMV combined with LTR promoter respectively, were constructed, based on the retroviral vector LNL6, and transferred into packaging cell line PA317 with electroporalion. Human dolling factor IX was delected in the cultured cells transduced with LNCIX and LIXSN but not in the cells transduced with LCIXSN. The viral titer of PA317/LNC1X was 800000 CFU per mL. With ELISA detection, it was found that the cells transduced with this vector can express human clotting factor IX at the level of 3.3μg per 106 cells in 24 h in human fibrosarcoma cells HT-1080 and 2.5μg per 106 cells in 24 h in hemophilia B patients' skin fibroblast HSF cells, and more than 80% of them were biologically active. The viral liter and expression of human FIX were increased, and the construction of retroviral vector backbone was improved and the safety was guaranteed as compared to those vectors used previously. These vectors may produce a sufficient quantily of factor IX proteins to cause the phenotypic modification for hemophilia B patients.展开更多
家蚕核多角体病毒(Bombyx mori Nuclear Polyhedrosis Virus.BmNPV)和家蚕细胞已成功地用来大量生产具有生物活性的重组蛋白。但是BmNPV的通用载体的类型较少。因此,本实验构建了BmNPV新型载体pBm92,该载体将多角体蛋白基因的起始密码AT...家蚕核多角体病毒(Bombyx mori Nuclear Polyhedrosis Virus.BmNPV)和家蚕细胞已成功地用来大量生产具有生物活性的重组蛋白。但是BmNPV的通用载体的类型较少。因此,本实验构建了BmNPV新型载体pBm92,该载体将多角体蛋白基因的起始密码ATG改变为ATT,然后在多角体蛋白基因的+12位外连接有5个外源基因的克隆位点。将HuIFN-β基因克隆在多角体蛋白基因的+12位后,构建了pBmIFN+12;同时构建HuIFN-β克隆在-3位后的转移栽体pBmIFN-3。将两种转移载体DNA分别与BmNPV基因组DNA共转染Bm-N细胞。利用重组病毒不产生多角体蛋白的特征,筛选重组病毒。用HuIFN-β基因探针与重组病毒DNA进行杂交鉴定。重组病毒BmIFN+12感染Bm-N细胞,其上清IFN活性最高时可达2.0×10~6IU/ml,将BmIFN+12注射5龄家蚕虫体,表达水平为50×10~7IU/ml,是HuIFN-β基因克隆在多角体蛋白基因的-3位后获得的重组病毒的表达量的2～4倍。家蚕体生产的rHulFN-β为糖基化蛋白具有天然HuIFN-β的抗原性。展开更多
文摘The construction of the high liter and highly expressed safety retroviral vector carrying human clotting factor IX cDNA is reported. Retroviral vectors LNCTX, LIXSN and LCTXSN, driven by hCMV, LTR and hCMV combined with LTR promoter respectively, were constructed, based on the retroviral vector LNL6, and transferred into packaging cell line PA317 with electroporalion. Human dolling factor IX was delected in the cultured cells transduced with LNCIX and LIXSN but not in the cells transduced with LCIXSN. The viral titer of PA317/LNC1X was 800000 CFU per mL. With ELISA detection, it was found that the cells transduced with this vector can express human clotting factor IX at the level of 3.3μg per 106 cells in 24 h in human fibrosarcoma cells HT-1080 and 2.5μg per 106 cells in 24 h in hemophilia B patients' skin fibroblast HSF cells, and more than 80% of them were biologically active. The viral liter and expression of human FIX were increased, and the construction of retroviral vector backbone was improved and the safety was guaranteed as compared to those vectors used previously. These vectors may produce a sufficient quantily of factor IX proteins to cause the phenotypic modification for hemophilia B patients.
文摘家蚕核多角体病毒(Bombyx mori Nuclear Polyhedrosis Virus.BmNPV)和家蚕细胞已成功地用来大量生产具有生物活性的重组蛋白。但是BmNPV的通用载体的类型较少。因此,本实验构建了BmNPV新型载体pBm92,该载体将多角体蛋白基因的起始密码ATG改变为ATT,然后在多角体蛋白基因的+12位外连接有5个外源基因的克隆位点。将HuIFN-β基因克隆在多角体蛋白基因的+12位后,构建了pBmIFN+12;同时构建HuIFN-β克隆在-3位后的转移栽体pBmIFN-3。将两种转移载体DNA分别与BmNPV基因组DNA共转染Bm-N细胞。利用重组病毒不产生多角体蛋白的特征,筛选重组病毒。用HuIFN-β基因探针与重组病毒DNA进行杂交鉴定。重组病毒BmIFN+12感染Bm-N细胞,其上清IFN活性最高时可达2.0×10~6IU/ml,将BmIFN+12注射5龄家蚕虫体,表达水平为50×10~7IU/ml,是HuIFN-β基因克隆在多角体蛋白基因的-3位后获得的重组病毒的表达量的2～4倍。家蚕体生产的rHulFN-β为糖基化蛋白具有天然HuIFN-β的抗原性。
